Welcome to factory-direct-buy
Hubei Yuancheng Saichuang Technology Co., Ltd
Hubei Yuancheng Saichuang Technology Co., Ltd
Sign in or Join Free Now!

Manufacturer Video

Contact Us

Street Address
496 Zhongshan Road
Country/Region
China (Mainland)/Hubei
Telephone

86-027-88215853

Popular Purity Steroids Powder Healthcare Female Drospirenone for Prevent Pregnancy CAS: 67392-87-4
Popular Purity Steroids Powder Healthcare Female Drospirenone for Prevent Pregnancy CAS: 67392-87-4
Supply Ability:
0 Gram/Grams per 0
Port:
Negotiable
Email:
Quantity:
Gram
  • Product Detils
  • Company Profile
Quick Details
Place of Origin:
China (Mainland)
Brand Name:
Pharmlab
Model Number:
67392-87-4
Packaging & Delivery
Disguised package; Foil bag
Product Description


Popular Purity Steroids Powder  Healthcare Female Drospirenone for Prevent Pregnancy CAS: 67392-87-4 


Quick Detail


Drospirenone

Product Name: Drospirenone

CAS No.: 67392-87-4

M.F.: C24H30O3

M.W.: 366.49

EINECS No.: 266-679-2

Assay: 99%

Packing: foil bag

Appearance: White crystalline powder

Trade mark:Pharmlab

Molecular structure


Description:


Drospirenone is one of several different progestins that are used in birth control pills. Most birth control pills (combination oral contraceptives) combine a synthetic version of the female hormone progesterone (referred to as a progestin) with a synthetic version of the female hormone estrogen. In addition to prevention of pregnancy, some birth control pills containing drospirenone are also approved to treat symptoms of premenstrual dysphoric disorder (PMDD), to treat moderate acne, and to raise folate levels, in women who choose to use an oral contraceptive for birth control


Applications:


Drospirenone is an aldosterone antagonist with potassium-sparing properties, though in most cases no increase of potassium levels is to be expected. In women with mild or moderate renal insufficiency, or in combination with chronic daily use of other potassium-sparing medications (ACE inhibitors, angiotensin II receptor antagonists, potassium-sparing diuretics, heparin, aldosterone antagonists, or NSAIDs), a potassium level should be checked after two weeks of use to test for hyperkalemia. In addition to contraindications common to all combined estrogen-progestin medications, drospirenone-containing medications are contraindicated in women with severe renal insufficiency according to European Medicines Agency (EMA)-approved labels, and contraindicated in women with renal insufficiency, adrenal insufficiency, or liver disease according to FDA-approved labels.


Women who take contraceptive pills containing drospirenone have a six- to sevenfold risk of developing thromboembolism (dangerous blood clots) compared to women who do not take any contraceptive pill, and have twice the risk (some epidemiological studies suggest thrice, according to the FDA) compared to women who take a contraceptive pill containing levonorgestrel, though the actual risk is small, in the neighborhood of 9 to 27 out of 10,000 women on an oral contraceptive for a year (up to 9 for levonorgestrel vs up to 27 for drospirenone, or about 0.09% vs 0.3% per year.)


While all oral contraceptives can increase the risk for venous thrombembolic events, including fatal blood clots, several studies have reported a greater risk for women taking contraceptives containing drospirenone. (Before becoming alarmed at the huge "relative" differences in risk, one must remember that the "actual" risks involved are quite small - in the neighborhood of 1 in 10,000 to 27 in 10,000 in a year).


When the U.S. Food and Drug Administration (FDA) became concerned about the risks of drospirenone, they funded studies based on the medical records of more than 800,000 women taking oral contraceptives. They found that the risk of VTE, which includes dangerous and potentially fatal blood clots, was 93% higher for women who had been taking oral contraceptives made with drospirenone for only 3 months or less and 290% higher for women taking drospirenone oral contraceptives for 7-12 months, compared to women taking other types of oral contraceptives. To determine the exact risk for women of different ages and different circumstances, further study is warranted.


The FDA recently updated the label for contraceptives containing drospirenone to include warnings for stopping use prior to and after surgery, and to warn that contraceptives with drospirenone may have a higher risk of dangerous blood clots.


Our Service:


1.Fast Delivery:We can delivery within 24 hours upon receipt of your payment.

2.Quality can be promised.Hot sell to Worldwide.

3.Payment Terms:T/T,BITCOIN,MoneyGram,WESTERN UNION,Paypal Available.


4.Free Sample available at any time.

5.Tracking your order at any time.Inform your order's further new situation at any time.

6.Package:Professional packing with professional materials.


Our advantage:


1.We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;

2.Quality:Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries.We can provide good references about our company.As for the quality of the products, we 're sure they can satisfy you well enough;

3.Package:Professional packing with professional materials

4.Delivery:We have products in stock, and we will deliver them soon when your PO arrived.Meanwhile we will give you the tracking number in order to make you know the exact location of the products.We will keep track of the product until they arrive you;We choose the best courier service for you, and with the delivery around 5-7 working days.

5.Service:Best Service with after-sales service and consultation


Please feel free to contact me,

Email:gcyj120@ycphar.com

whatsapp:+8615308670259


Drospirenone 3_.jpg


Send your message to this manufacturer
Email:
Message:
Your message must be between 20-8000 characters
 

© 2012 - 2015, factory-direct-buy.com All rights reserved.